The Eclipse System was studied in a multi-center clinical trial in the United States, called LIFE. The LIFE Study demonstrated the effectiveness and safety of the Eclipse System. One hundred and ten women who were eligible to be fitted with the Eclipse Insert enrolled in the study. Sixty-one women achieved a successful fit and went on to a one-month evaluation period.
The LIFE study was led by Holly E. Richter, Ph.D., M.D., Director of the Division of Urogynecology and Pelvic Reconstructive Surgery at the University of Alabama at Birmingham, and past President of the Society for Gynecological Surgeons (SGS). Primary results of this study were published in Obstetrics & Gynecology, and an additional analysis of the impact of Eclipse on bowel symptoms associated with ABL was published in Diseases of the Colon and Rectum.